500 patients67,039 observations150 daysLIVE

Patient P-03437

Synthetic patientONX-7 · Day 139 · 45–54 · F · baseline S12Open companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
59%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S12
  2. Day 31 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 31.

Primary contributors, last 14 days
  • GI instability+29
  • Inflammatory activity+17
  • Nutritional resilience-15
  • Treatment adherence-5
  • Toxicity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    Dosing / Timing Recommendation DT-01
    60%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 79% showed improvement
    • median effect visible after 5 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling 45
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
    • Mucosal barrier integrity 40
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • WearableSleep 5.3 h, below personal baseline
    • Autonomic recovery 40
      • Wearable2,556 steps/day
      • WearableShort sleep window
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Rapid metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4.4 · butyrate capacity 54/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    66 ms
    Sleep
    6.3 h
    Steps
    2,738
    Resting HR
    64 bpm
    Daily log: GI score 39, nutritional resilience 58, adherence 78.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0301541%S1929
    P-0313241%S1533
    P-0316240%S0728
    P-0329440%S0432
    P-0335540%S0231
    P-0340940%S1228
    P-0301239%S1113
    P-0317739%S0128
    P-0332639%S0832
    P-0340039%S2031
    P-0340639%S1931
    P-0321138%S0732